First Choice Healthcare Solutions, Inc. (FCHS): Operating Cash Flow
-$549.0K
Year ended 2025-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$549.0K | n/m | 2026-03-11, From 2025-01-01 |
| 2024-12-31 | -$1.71M | n/m | 2026-03-11, From 2024-01-01 |
| 2023-12-31 | -$6.80M | n/m | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | -$3.38M | n/a | 2024-05-13, From 2022-01-01 |
| No annual figure between 2017-12-31 and 2022-12-31. | |||
| 2017-12-31 | -$1.55M | n/m | 2018-04-03, From 2017-01-01 |
| 2016-12-31 | -$3.51M | n/m | 2018-04-03, From 2016-01-01 |
| 2015-12-31 | $483.9K | n/m | 2017-04-03, From 2015-01-01 |
| 2014-12-31 | -$363.9K | n/m | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | -$1.26M | n/m | 2015-04-15, From 2013-01-01 |
| 2012-12-31 | -$788.9K | n/m | 2013-04-01, From 2012-01-01 |
| 2011-12-31 | $66.3K | -84.0% | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | $414.4K | n/a | 2012-03-30, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| First Choice Healthcare Solutions, Inc. (FCHS) | 2025-12-31 | -$549.0K | n/m |
| BioNexus Gene Lab Corp (BGLC) | 2025-12-31 | -$1.84M | n/m |
| Aclarion, Inc. (ACON) | 2025-12-31 | -$7.16M | n/m |
| Advanced Biomed Inc. (ADVB) | 2026-06-30 | -$1.95M | n/m |
| YD Bio Ltd (YDES) | 2025-12-31 | -$6.60M | n/m |
| CapForce Inc. (CFOR) | 2025-12-31 | -$1.18M | n/m |
| American Shared Hospital Services (AMS) | 2025-12-31 | $3.10M | n/m |
| Exagen Inc. (XGN) | 2025-12-31 | -$13.62M | n/m |
| Ludwig Enterprises, Inc. (LUDG) | 2025-12-31 | -$644.8K | n/m |
Compare FCHS, BGLC, ACON, ADVB side by side · Screen every company in Services-Medical Laboratories ↗